Search

Your search keyword '"Schutz, Fabio A."' showing total 223 results
Start Over Author "Schutz, Fabio A."
223 results on '"Schutz, Fabio A."'

1. Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update

Author

Soares, Andrey, Monteiro, Fernando Sabino Marques, da Trindade, Karine Martins, Silva, Adriano Gonçalves e, Cardoso, Ana Paula Garcia, Sasse, André Deeke, Fay, André P., Carneiro, André Paternò Castello Dias, Alencar Junior, Antonio Machado, de Andrade Mota, Augusto César, Santucci, Bruno, da Motta Girardi, Daniel, Herchenhorn, Daniel, Araújo, Daniel Vilarim, Jardim, Denis Leonardo, Bastos, Diogo Assed, Rosa, Diogo Rodrigues, Schutz, Fabio A., Kater, Fábio Roberto, da Silva Marinho, Felipe, Maluf, Fernando Cotait, de Oliveira, Fernando Nunes Galvão, Vidigal, Fernando, Morbeck, Igor Alexandre Protzner, Rinck Júnior, Jose Augusto, Costa, Leonardo Atem G. A., Maia, Manuel Caitano Dias Ferreira, Zereu, Manuela, Freitas, Marcelo Roberto Pereira, Dias, Mariane Sousa Fontes, Tariki, Milena Shizue, Muniz, Pamela, Beato, Patrícia Medeiros Milhomem, Lages, Paulo Sérgio Moraes, Velho, Pedro Isaacsson, de Carvalho, Ricardo Saraiva, Mariano, Rodrigo Coutinho, de Araújo Cavallero, Sandro Roberto, Oliveira, Thiago Martins, Souza, Vinicius Carrera, Smaletz, Oren, and de Cássio Zequi, Stênio

Published
2024
Full Text
View/download PDF

2. Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study

Author

Grande, Enrique, Arranz, José Á, De Santis, Maria, Bamias, Aristotelis, Kikuchi, Eiji, del Muro, Xavier Garcia, Park, Se Hoon, De Giorgi, Ugo, Alekseev, Boris, Mencinger, Marina, Izumi, Kouji, Schutz, Fabio A, Puente, Javier, Li, Jian-Ri, O'Donnell, Peter H, Kalebasty, Arash Rezazadeh, Ye, Dingwei, Mariathasan, Sanjeev, Bene-Tchaleu, FabioIa, Bernhard, Sandrine, Lee, Chooi, Davis, Ian D, and Galsky, Matthew D

Published
2024
Full Text
View/download PDF

3. Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 study

Author

Bamias, Aristotelis, Davis, Ian D, Galsky, Matthew D, Arranz, José Á, Kikuchi, Eiji, Grande, Enrique, del Muro, Xavier Garcia, Park, Se Hoon, De Giorgi, Ugo, Alekseev, Boris, Mencinger, Marina, Izumi, Kouji, Schutz, Fabio A, Puente, Javier, Li, Jian-Ri, Panni, Stefano, Gumus, Mahmut, Özgüroğlu, Mustafa, Mariathasan, Sanjeev, Poloz, Yekaterina, Bene-Tchaleu, Fabiola, Lee, Chooi, Bernhard, Sandrine, and De Santis, Maria

Published
2024
Full Text
View/download PDF

5. Multicenter Database of Patients with Germ-Cell Tumors: A Latin American Cooperative Oncology Group Registry (LACOG 0515)

Author

Bastos, Diogo A., Gongora, Aline Bobato Lara, Dzik, Carlos, Jardim, Denis Leonardo, Piva, Marina, Carcano, Flavio Mavignier, Bertollo, Glaucio, Trindade, Karine, Fontes, Mariane Sousa, Soares, Andrey, Reinert, Tomas, De Cassia Costamilan, Rita, Villarroel, Rodrigo Ughini, Watarai, Gabriel, Gazola, Antonia Angeli, Preto, Daniel D Almeida, Mutti, Haila, Bonalumi dos Santos, Marcela, Mariano, Rodrigo Coutinho, Binotto, Monique, Carvalho, Monique Maciel, Oliveira, Veronica Patrícia da Costa, Gomes, Rafaela, Rebelatto, Taiane F, Schutz, Fabio A., Smaletz, Oren, and Fay, Andre P.

Published
2023
Full Text
View/download PDF

6. “Non-metastatic, Castration-resistant Prostate Cancer: Diagnostic and Treatment Recommendations by an Expert Panel from Brazil”

Author

Jardim, Denis L., Gonçalves e Silva, Adriano, Pompeo, Alexandre Saad Fere Lima, Sarkis, Alvaro Sadek, Cardoso, Ana Paula Garcia, Sasse, Andre Deeke, Fay, Andre Poisl, Soares, Andrey, Pompeo, Antonio Carlos Lima, Carneiro, Arie, Kann, Ariel Galapo, Fogassa, Camilla, De Freitas, Celso Heitor, Junior, Chade, Daher Cezar, Herchenhorn, Daniel, De Almeida, Daniel Vargas Pivato, Da Rosa, Diogo Augusto Rodrigues, Wiermann, Evanius Garcia, Schutz, Fabio Augusto Barros, Kater, Fabio Roberto, De Moura, Fernando, Korkes, Fernando, Meyer, Fernando, De Oliveira, Fernando Nunes Galvao, Sabino, Fernando, Almeida, Gilberto Laurino, Avanço, Guilherme, Guimaraes, Gustavo Cardoso, Lemos, Gustavo Caserta, Carvalhal, Gustavo Franco, Kim, Hanna, Morbeck, Igor Protzner, Campagnari, Joao Carlos, Rinck, Jose Augusto, Junior, Da Ponte, José Ricardo Tuma, Da Trindade, Karine Martins, Atem, Leonardo, Borges, Leonardo, Nogueira, Lucas Mendes, Batista, Lucas Teixeira e Aguiar, Maia, Manuel Caitano, Sadi, Marcus Vinicius, Rocha, Maria Alzira Almeida, Luz, Murilo De Almeida, Smaletz, Oren, Lages, Paulo Sergio Moraes, Matuda, Raquel Midori Koga, Reis, Rodolfo Borges Dos, Indio, Rodrigo Frota, Fernandes, Roni De Carvalho, Cavallero, Sandro Roberto, Souza, Vinicius Carrera, Busato, Wilson, Jr, Alfer, Wladimir, Junior, and Maluf, Fernando

Published
2023
Full Text
View/download PDF

8. Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 study

Author

Bamias, Aristotelis, primary, Davis, Ian D, additional, Galsky, Matthew D, additional, Arranz, José Á, additional, Kikuchi, Eiji, additional, Grande, Enrique, additional, del Muro, Xavier Garcia, additional, Park, Se Hoon, additional, De Giorgi, Ugo, additional, Alekseev, Boris, additional, Mencinger, Marina, additional, Izumi, Kouji, additional, Schutz, Fabio A, additional, Puente, Javier, additional, Li, Jian-Ri, additional, Panni, Stefano, additional, Gumus, Mahmut, additional, Özgüroğlu, Mustafa, additional, Mariathasan, Sanjeev, additional, Poloz, Yekaterina, additional, Bene-Tchaleu, Fabiola, additional, Lee, Chooi, additional, Bernhard, Sandrine, additional, and De Santis, Maria, additional

Published
2023
Full Text
View/download PDF

9. Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study

Author

Grande, Enrique, primary, Arranz, José Á, additional, De Santis, Maria, additional, Bamias, Aristotelis, additional, Kikuchi, Eiji, additional, del Muro, Xavier Garcia, additional, Park, Se Hoon, additional, De Giorgi, Ugo, additional, Alekseev, Boris, additional, Mencinger, Marina, additional, Izumi, Kouji, additional, Schutz, Fabio A, additional, Puente, Javier, additional, Li, Jian-Ri, additional, O'Donnell, Peter H, additional, Kalebasty, Arash Rezazadeh, additional, Ye, Dingwei, additional, Mariathasan, Sanjeev, additional, Bene-Tchaleu, FabioIa, additional, Bernhard, Sandrine, additional, Lee, Chooi, additional, Davis, Ian D, additional, and Galsky, Matthew D, additional

Published
2023
Full Text
View/download PDF

10. Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG)

Author

Soares, Andrey, Monteiro, Fernando Sabino Marques, Maluf, Fernando Cotait, Bastos, Diogo Assed, Jardim, Denis Leonardo, Sasse, André Deeke, Gonçalves e Silva, Adriano, Fay, André P., da Rosa, Diogo Augusto Rodrigues, Wierman, Evanius, Kater, Fabio, Schutz, Fabio A., de Oliveira, Fernando Nunes Galvão, Morbeck, Igor Alexandre Protzner, Rinck, Jr, José Augusto, da Trindade, Karine Martins, Maia, Manuel Caitano, Souza, Vinicius Carrera, da Silva Neto, Deusdedit Cortez Vieira, de Almeida e Paula, Felipe, Korkes, Fernando, Carvalhal, Gustavo Franco, Nogueira, Lucas, de Carvalho Fernandes, Roni, dos Reis, Rodolfo Borges, Matheus, Wagner Eduardo, Busato, Jr, Wilson Francisco Schreiner, da Costa, Walter Henriques, and de Cássio Zequi, Stênio

Published
2020
Full Text
View/download PDF

13. Use of Immunotherapy in Patients With Cancer During the COVID-19 Pandemic

Author

Soares, Andrey, Schutz, Fabio A., Bastos, Diogo Assed, Jardim, Denis, Sabino, Fernando, and Monteiro, Marques

Subjects
Bayer AG, Pfizer Inc., Bristol-Myers Squibb Co., AstraZeneca PLC, Carboplatin, Cancer patients -- Drug therapy, Immunotherapy, Squamous cell carcinoma -- Drug therapy, Cancer -- Care and treatment, Health
Abstract

THE CASE In an asymptomatic 77-year-old woman, former 55 pack-years smoker, a routine X-ray showed a 45-mm superior left lobe lesion (Figure 1). A chest CT scan confirmed a 36-mm [...]

Published
2020

14. Consensus on Treatment and Follow-Up for Biochemical Recurrence in Castration-Sensitive Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries

Author

Monteiro, Fernando S. M., Schutz, Fabio A., Morbeck, Igor A. P., Bastos, Diogo A., de Padua, Fernando V., Costa, Leonardo A. G. A., Maia, Manuel C., Rinck, Jose A., Jr, Zequi, Stenio de Cassio, da Trindade, Karine M., Alfer, Wladimir, Jr, Nahas, William C., dos Santos, Lucas V., Ferrigno, Robson, da Rosa, Diogo A. R., Sade, Juan P., Orlandi, Francisco J., de Oliveira, Fernando N. G., and Soares, Andrey

Published
2021
Full Text
View/download PDF

15. Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma

Author

Choueiri, Toni K., primary, Powles, Thomas, additional, Albiges, Laurence, additional, Burotto, Mauricio, additional, Szczylik, Cezary, additional, Zurawski, Bogdan, additional, Yanez Ruiz, Eduardo, additional, Maruzzo, Marco, additional, Suarez Zaizar, Alberto, additional, Fein, Luis E., additional, Schutz, Fabio A., additional, Heng, Daniel Y.C., additional, Wang, Fong, additional, Mataveli, Fabio, additional, Chang, Yu-Lin, additional, van Kooten Losio, Maximiliano, additional, Suarez, Cristina, additional, and Motzer, Robert J., additional

Published
2023
Full Text
View/download PDF

16. Data from The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non–Clear Cell Renal Cell Carcinoma

Author

McKay, Rana R., primary, Bossé, Dominick, primary, Xie, Wanling, primary, Wankowicz, Stephanie A.M., primary, Flaifel, Abdallah, primary, Brandao, Raphael, primary, Lalani, Aly-Khan A., primary, Martini, Dylan J., primary, Wei, Xiao X., primary, Braun, David A., primary, Van Allen, Eliezer, primary, Castellano, Daniel, primary, De Velasco, Guillermo, primary, Wells, J. Connor, primary, Heng, Daniel Y., primary, Fay, Andre P., primary, Schutz, Fabio A., primary, Hsu, JoAnn, primary, Pal, Sumanta K., primary, Lee, Jae Lyun, primary, Hsieh, James J., primary, Harshman, Lauren C., primary, Signoretti, Sabina, primary, Motzer, Robert J., primary, Feldman, Darren, primary, and Choueiri, Toni K., primary

Published
2023
Full Text
View/download PDF

18. Supplementary Data from The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non–Clear Cell Renal Cell Carcinoma

Author

McKay, Rana R., primary, Bossé, Dominick, primary, Xie, Wanling, primary, Wankowicz, Stephanie A.M., primary, Flaifel, Abdallah, primary, Brandao, Raphael, primary, Lalani, Aly-Khan A., primary, Martini, Dylan J., primary, Wei, Xiao X., primary, Braun, David A., primary, Van Allen, Eliezer, primary, Castellano, Daniel, primary, De Velasco, Guillermo, primary, Wells, J. Connor, primary, Heng, Daniel Y., primary, Fay, Andre P., primary, Schutz, Fabio A., primary, Hsu, JoAnn, primary, Pal, Sumanta K., primary, Lee, Jae Lyun, primary, Hsieh, James J., primary, Harshman, Lauren C., primary, Signoretti, Sabina, primary, Motzer, Robert J., primary, Feldman, Darren, primary, and Choueiri, Toni K., primary

Published
2023
Full Text
View/download PDF

19. Supplementary Tables 1 through 4 from Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients

Author

De Velasco, Guillermo, primary, Je, Youjin, primary, Bossé, Dominick, primary, Awad, Mark M., primary, Ott, Patrick A., primary, Moreira, Raphael B., primary, Schutz, Fabio, primary, Bellmunt, Joaquim, primary, Sonpavde, Guru P., primary, Hodi, F. Stephen, primary, and Choueiri, Toni K., primary

Published
2023
Full Text
View/download PDF

20. Supplementary Figures 7 - 14, Tables 3 - 7 from Integrative Analysis of 1q23.3 Copy-Number Gain in Metastatic Urothelial Carcinoma

Author

Riester, Markus, primary, Werner, Lillian, primary, Bellmunt, Joaquim, primary, Selvarajah, Shamini, primary, Guancial, Elizabeth A., primary, Weir, Barbara A., primary, Stack, Edward C., primary, Park, Rachel S., primary, O'Brien, Robert, primary, Schutz, Fabio A.B., primary, Choueiri, Toni K., primary, Signoretti, Sabina, primary, Lloreta, Josep, primary, Marchionni, Luigi, primary, Gallardo, Enrique, primary, Rojo, Federico, primary, Garcia, Denise I., primary, Chekaluk, Yvonne, primary, Kwiatkowski, David J., primary, Bochner, Bernard H., primary, Hahn, William C., primary, Ligon, Azra H., primary, Barletta, Justine A., primary, Loda, Massimo, primary, Berman, David M., primary, Kantoff, Philip W., primary, Michor, Franziska, primary, and Rosenberg, Jonathan E., primary

Published
2023
Full Text
View/download PDF

21. Supplementary Figure Legends from Integrative Analysis of 1q23.3 Copy-Number Gain in Metastatic Urothelial Carcinoma

Author

Riester, Markus, primary, Werner, Lillian, primary, Bellmunt, Joaquim, primary, Selvarajah, Shamini, primary, Guancial, Elizabeth A., primary, Weir, Barbara A., primary, Stack, Edward C., primary, Park, Rachel S., primary, O'Brien, Robert, primary, Schutz, Fabio A.B., primary, Choueiri, Toni K., primary, Signoretti, Sabina, primary, Lloreta, Josep, primary, Marchionni, Luigi, primary, Gallardo, Enrique, primary, Rojo, Federico, primary, Garcia, Denise I., primary, Chekaluk, Yvonne, primary, Kwiatkowski, David J., primary, Bochner, Bernard H., primary, Hahn, William C., primary, Ligon, Azra H., primary, Barletta, Justine A., primary, Loda, Massimo, primary, Berman, David M., primary, Kantoff, Philip W., primary, Michor, Franziska, primary, and Rosenberg, Jonathan E., primary

Published
2023
Full Text
View/download PDF

22. Supplementary Figures 1 - 5, Tables 1 - 2 from Integrative Analysis of 1q23.3 Copy-Number Gain in Metastatic Urothelial Carcinoma

Author

Riester, Markus, primary, Werner, Lillian, primary, Bellmunt, Joaquim, primary, Selvarajah, Shamini, primary, Guancial, Elizabeth A., primary, Weir, Barbara A., primary, Stack, Edward C., primary, Park, Rachel S., primary, O'Brien, Robert, primary, Schutz, Fabio A.B., primary, Choueiri, Toni K., primary, Signoretti, Sabina, primary, Lloreta, Josep, primary, Marchionni, Luigi, primary, Gallardo, Enrique, primary, Rojo, Federico, primary, Garcia, Denise I., primary, Chekaluk, Yvonne, primary, Kwiatkowski, David J., primary, Bochner, Bernard H., primary, Hahn, William C., primary, Ligon, Azra H., primary, Barletta, Justine A., primary, Loda, Massimo, primary, Berman, David M., primary, Kantoff, Philip W., primary, Michor, Franziska, primary, and Rosenberg, Jonathan E., primary

Published
2023
Full Text
View/download PDF

23. Supplementary Figure 6 from Integrative Analysis of 1q23.3 Copy-Number Gain in Metastatic Urothelial Carcinoma

Author

Riester, Markus, primary, Werner, Lillian, primary, Bellmunt, Joaquim, primary, Selvarajah, Shamini, primary, Guancial, Elizabeth A., primary, Weir, Barbara A., primary, Stack, Edward C., primary, Park, Rachel S., primary, O'Brien, Robert, primary, Schutz, Fabio A.B., primary, Choueiri, Toni K., primary, Signoretti, Sabina, primary, Lloreta, Josep, primary, Marchionni, Luigi, primary, Gallardo, Enrique, primary, Rojo, Federico, primary, Garcia, Denise I., primary, Chekaluk, Yvonne, primary, Kwiatkowski, David J., primary, Bochner, Bernard H., primary, Hahn, William C., primary, Ligon, Azra H., primary, Barletta, Justine A., primary, Loda, Massimo, primary, Berman, David M., primary, Kantoff, Philip W., primary, Michor, Franziska, primary, and Rosenberg, Jonathan E., primary

Published
2023
Full Text
View/download PDF

24. Supplementary Figures 15 - 17, Table 8 from Integrative Analysis of 1q23.3 Copy-Number Gain in Metastatic Urothelial Carcinoma

Author

Riester, Markus, primary, Werner, Lillian, primary, Bellmunt, Joaquim, primary, Selvarajah, Shamini, primary, Guancial, Elizabeth A., primary, Weir, Barbara A., primary, Stack, Edward C., primary, Park, Rachel S., primary, O'Brien, Robert, primary, Schutz, Fabio A.B., primary, Choueiri, Toni K., primary, Signoretti, Sabina, primary, Lloreta, Josep, primary, Marchionni, Luigi, primary, Gallardo, Enrique, primary, Rojo, Federico, primary, Garcia, Denise I., primary, Chekaluk, Yvonne, primary, Kwiatkowski, David J., primary, Bochner, Bernard H., primary, Hahn, William C., primary, Ligon, Azra H., primary, Barletta, Justine A., primary, Loda, Massimo, primary, Berman, David M., primary, Kantoff, Philip W., primary, Michor, Franziska, primary, and Rosenberg, Jonathan E., primary

Published
2023
Full Text
View/download PDF

25. Selpercatinib and capmatinib combination promotes sustained complete response in novel ISOC1-RET fusion lung cancer after resistance to RET inhibitor via MET amplification: Case Report.

Author

Abner Leite, Caio, Pierri Carvalho, Raíssa, Marques da Costa, Felipe, Kreling Medeiros, Augusto, Augusto Schutz, Fabio, and William Jr., William Nassib

Subjects
LUNG cancer, NON-small-cell lung carcinoma, ANAPLASTIC lymphoma kinase
Abstract

RET fusions occur in 1-2% of non-small cell lung cancer. Selpercatinib and pralsetinib are selective RET inhibitors with significant improvement of outcome in patients with tumor harboring RET fusion; however, resistance mechanisms appear frequently, mainly driven by MAPK pathway bypass, secondary RET mutations, or in 5% via MET amplification. Co-inhibition of RET and MET is a compelling strategy for overcoming MET-dependent resistance to RET inhibitors and potentially other inhibitors. To our knowledge, this is the first report of a novel ISOC1-RET fusion lung cancer with a durable complete response to selpercatinib, with resistance via MET amplification, which was overcome by the successful combination of selpercatinib and capmatinib. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

26. Outcomes by IMDC risk in the COSMIC-313 phase 3 trial evaluating cabozantinib (C) plus nivolumab (N) and ipilimumab (I) in first-line advanced RCC (aRCC) of IMDC intermediate or poor risk.

Author

Powles, Thomas, primary, Motzer, Robert J., additional, Albiges, Laurence, additional, Suárez, Cristina, additional, Schutz, Fabio A. B., additional, Heng, Daniel Yick Chin, additional, Chevreau, Christine, additional, Kanesvaran, Ravindran, additional, Gurney, Howard, additional, Wang, Fong, additional, Mataveli, Fabio, additional, Chang, Yu-Lin, additional, van Kooten Losio, Maximiliano, additional, and Choueiri, Toni K., additional

Published
2023
Full Text
View/download PDF

28. Multicenter Database of Patients with Germ-Cell Tumors: A Latin American Cooperative Oncology Group Registry (LACOG 0515)

Author

Bastos, Diogo A., primary, Gongora, Aline Bobato Lara, additional, Dzik, Carlos, additional, Jardim, Denis Leonardo, additional, Piva, Marina, additional, Carcano, Flavio Mavignier, additional, Bertollo, Glaucio, additional, Trindade, Karine, additional, Fontes, Mariane Sousa, additional, Soares, Andrey, additional, Reinert, Tomas, additional, De Cassia Costamilan, Rita, additional, Villarroel, Rodrigo Ughini, additional, Watarai, Gabriel, additional, Gazola, Antonia Angeli, additional, Preto, Daniel D Almeida, additional, Mutti, Haila, additional, Bonalumi dos Santos, Marcela, additional, Mariano, Rodrigo Coutinho, additional, Binotto, Monique, additional, Carvalho, Monique Maciel, additional, Oliveira, Veronica Patrícia da Costa, additional, Gomes, Rafaela, additional, Rebelatto, Taiane F, additional, Schutz, Fabio A., additional, Smaletz, Oren, additional, and Fay, Andre P., additional

Published
2022
Full Text
View/download PDF

31. Survival analysis of the randomized phase II trial to investigate androgen signaling inhibitors with or without androgen deprivation therapy (ADT) for castration-sensitive prostate cancer: LACOG 0415.

Author

Maluf, Fernando Cotait, primary, Soares, Andrey, additional, Bastos, Diogo Assed, additional, Schutz, Fabio A. B., additional, Cronemberger, Eduardo, additional, Luz, Murilo, additional, Martins, Suelen P. S., additional, Muniz, David Queiroz Borges, additional, Carcano, Flavio Mavignier, additional, Smaletz, Oren, additional, Peixoto, Fábio A, additional, Gomes, Andrea J, additional, Cruz, Felipe Melo, additional, Franke, Fabio, additional, Herchenhorn, Daniel, additional, Gidekel, Rosemarie, additional, Rebelatto, Taiane Francieli, additional, Gomes, Rafaela, additional, Souza, Vinicius Carrera, additional, and Fay, Andre P., additional

Published
2022
Full Text
View/download PDF

40. Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

Author

Motzer, Robert J., Escudier, Bernard, McDermott, David F., George, Saby, Hammers, Hans J., Srinivas, Sandhya, Tykodi, Scott S., Sosman, Jeffrey A., Procopio, Giuseppe, Plimack, Elizabeth R., Castellano, Daniel, Choueiri, Toni K., Gurney, Howard, Donskov, Frede, Bono, Petri, Wagstaff, John, Gauler, Thomas C., Ueda, Takeshi, Tomita, Yoshihiko, Schutz, Fabio A., Kollmannsberger, Christian, Larkin, James, Ravaud, Alain, Simon, Jason S., Xu, Li-An, Waxman, Ian M., and Sharma, Padmanee

Published
2015
Full Text
View/download PDF

42. sj-pdf-1-tam-10.1177_1758835920985464 – Supplemental material for Optimizing outcomes for patients with metastatic prostate cancer: insights from South East Asia Expert Panel

Author

Schutz, Fabio Augusto Barros, Ekaphop Sirachainan, Shanggar Kuppusamy, Nguyen Thi Thai Hoa, Thitiya Dejthevaporn, Badrulhisham Bahadzor, Toan, Vu Quang, Phichai Chansriwong, Adlinda Alip, Nguyen Thi Minh Hue, Napa Parinyanitikul, Tan, Ai Lian, Hoang, Vu Dinh Khanh, Piyawan Tienchaiananda, Chinchapattanam, Sai Naga Deepak, and Garg, Amit

Subjects
110203 Respiratory Diseases, FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 111299 Oncology and Carcinogenesis not elsewhere classified
Abstract

Supplemental material, sj-pdf-1-tam-10.1177_1758835920985464 for Optimizing outcomes for patients with metastatic prostate cancer: insights from South East Asia Expert Panel by Fabio Augusto Barros Schutz, Ekaphop Sirachainan, Shanggar Kuppusamy, Nguyen Thi Thai Hoa, Thitiya Dejthevaporn, Badrulhisham Bahadzor, Vu Quang Toan, Phichai Chansriwong, Adlinda Alip, Nguyen Thi Minh Hue, Napa Parinyanitikul, Ai Lian Tan, Vu Dinh Khanh Hoang, Piyawan Tienchaiananda, Sai Naga Deepak Chinchapattanam and Amit Garg in Therapeutic Advances in Medical Oncology

Published
2021
Full Text
View/download PDF

44. Consensus on diagnosis and management of non-metastatic castration resistant prostate cancer in Brazil: focus on patient, selection, treatment efficacy, side effects and physician's perception according to patient comorbidities

Author

Maluf, Fernando, primary, Soares, Andrey, additional, Avanço, Guilherme, additional, Hada, Aline Lury, additional, Cardoso, Ana Paula Garcia, additional, Carneiro, Arie, additional, Herchenhorn, Daniel, additional, Jardim, Denis Leonardo Fontes, additional, Schutz, Fabio Augusto, additional, Kater, Fabio Roberto, additional, Pereira, Felipe Moraes Toledo, additional, Monteiro, Fernando Sabino Marques, additional, Morbeck, Igor Alexandre Protzner, additional, Reolon, João Francisco Navarro, additional, Trindade, Karine Martins da, additional, Andrade, Livia Maria Querino da Silvo, additional, Nogueira, Lucas Mendes, additional, Furoni, Renato, additional, Natel, Ricardo Azze, additional, Reis, Rodolfo Borges dos, additional, Fogace, Rodrigo Nogueira, additional, and Souza, Vinicius Carrera, additional

Published
2021
Full Text
View/download PDF

45. Health-related quality-of-life (HRQoL) analysis from a randomized phase II trial of androgen signaling inhibitors with or without androgen deprivation therapy (ADT) for castration-sensitive prostate cancer: LACOG 0415.

Author

Soares, Andrey, primary, Bastos, Diogo Assed, additional, Schutz, Fabio A. B., additional, Cronemberger, Eduardo, additional, Luz, Murilo, additional, Martins, Suelen P. S., additional, Muniz, David Queiroz Borges, additional, Carcano, Flavio Mavignier, additional, Smaletz, Oren, additional, Peixoto, Fábio A, additional, Gomes, Andrea Juliana, additional, Cruz, Felipe Melo, additional, Franke, Fabio Andre, additional, Herchenhorn, Daniel, additional, Gidekel, Rosemarie, additional, Rebelatto, Taiane Francieli, additional, Gomes, Rafaela, additional, Souza, Vinicius Carrera, additional, Fay, Andre P., additional, and Maluf, Fernando C., additional

Published
2021
Full Text
View/download PDF

46. Immune manifestations with checkpoint inhibitors in a single Brazilian center: experience and literature review

Author

Schmerling, Rafael A, primary, Buzaid, Antonio C, additional, Haddad, Carolina K, additional, Schutz, Fabio AB, additional, Kater, Fabio R, additional, Pimenta, Juliana, additional, Maluf, Fernando, additional, William, William N, additional, Lopes, Camila, additional, Bromberg, Dafne R, additional, Oliveira, Ana C, additional, Golmia, Ricardo, additional, and Scheinberg, Morton, additional

Published
2021
Full Text
View/download PDF

48. Optimizing outcomes for patients with metastatic prostate cancer: insights from South East Asia Expert Panel

Author

Schutz, Fabio Augusto Barros, primary, Sirachainan, Ekaphop, additional, Kuppusamy, Shanggar, additional, Hoa, Nguyen Thi Thai, additional, Dejthevaporn, Thitiya, additional, Bahadzor, Badrulhisham, additional, Toan, Vu Quang, additional, Chansriwong, Phichai, additional, Alip, Adlinda, additional, Hue, Nguyen Thi Minh, additional, Parinyanitikul, Napa, additional, Tan, Ai Lian, additional, Hoang, Vu Dinh Khanh, additional, Tienchaiananda, Piyawan, additional, Chinchapattanam, Sai Naga Deepak, additional, and Garg, Amit, additional

Published
2021
Full Text
View/download PDF

50. Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long‐term follow‐up of the randomized, open‐label, phase 3 CheckMate 025 trial

Author

Motzer, Robert J., primary, Escudier, Bernard, additional, George, Saby, additional, Hammers, Hans J., additional, Srinivas, Sandhya, additional, Tykodi, Scott S., additional, Sosman, Jeffrey A., additional, Plimack, Elizabeth R., additional, Procopio, Giuseppe, additional, McDermott, David F., additional, Castellano, Daniel, additional, Choueiri, Toni K., additional, Donskov, Frede, additional, Gurney, Howard, additional, Oudard, Stéphane, additional, Richardet, Martin, additional, Peltola, Katriina, additional, Alva, Ajjai S., additional, Carducci, Michael, additional, Wagstaff, John, additional, Chevreau, Christine, additional, Fukasawa, Satoshi, additional, Tomita, Yoshihiko, additional, Gauler, Thomas C., additional, Kollmannsberger, Christian K., additional, Schutz, Fabio A., additional, Larkin, James, additional, Cella, David, additional, McHenry, M. Brent, additional, Saggi, Shruti Shally, additional, and Tannir, Nizar M., additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results